Serving hundreds of leading biopharmaceutical companies globally:

Generated: November 14, 2018

DrugPatentWatch Database Preview

Biomarin Pharm Company Profile

« Back to Dashboard

What is the competitive landscape for BIOMARIN PHARM, and what generic alternatives to BIOMARIN PHARM drugs are available?

BIOMARIN PHARM has two approved drugs.

There are eleven US patents protecting BIOMARIN PHARM drugs.

Summary for Biomarin Pharm

US Patents:	11
Tradenames:	1
Ingredients:	1
NDAs:	2
Patent Litigation for Biomarin Pharm:	See patent lawsuits for Biomarin Pharm

Drugs and US Patents for Biomarin Pharm

+ Get email alerts for changes to this table

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Biomarin Pharm	KUVAN	sapropterin dihydrochloride	POWDER;ORAL	205065-001	Dec 19, 2013		RX	Yes	Yes	9,216,178	➤ Sign Up	Y			➤ Sign Up
Biomarin Pharm	KUVAN	sapropterin dihydrochloride	TABLET;ORAL	022181-001	Dec 13, 2007		RX	Yes	Yes	7,947,681*PED	➤ Sign Up			Y	➤ Sign Up
Biomarin Pharm	KUVAN	sapropterin dihydrochloride	POWDER;ORAL	205065-001	Dec 19, 2013		RX	Yes	Yes	7,566,714*PED	➤ Sign Up			Y	➤ Sign Up
Biomarin Pharm	KUVAN	sapropterin dihydrochloride	POWDER;ORAL	205065-001	Dec 19, 2013		RX	Yes	Yes	8,067,416*PED	➤ Sign Up			Y	➤ Sign Up
Biomarin Pharm	KUVAN	sapropterin dihydrochloride	POWDER;ORAL	205065-002	Oct 27, 2015		RX	Yes	No	8,067,416*PED	➤ Sign Up			Y	➤ Sign Up
Biomarin Pharm	KUVAN	sapropterin dihydrochloride	POWDER;ORAL	205065-001	Dec 19, 2013		RX	Yes	Yes	RE43797*PED	➤ Sign Up			Y	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Paragraph IV (Patent) Challenges for BIOMARIN PHARM drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Powder for Oral Solution	100 mg per packet	➤ Subscribe	2015-11-09
➤ Subscribe	Tablets	100 mg	➤ Subscribe	2014-05-30
➤ Subscribe	Powder for Oral Solution	500 mg/packet	➤ Subscribe	2016-12-20

International Patents for Biomarin Pharm Drugs

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Country	Document Number	Estimated Expiration
South Korea	20100016445	➤ Sign Up
Israel	175529	➤ Sign Up
Canada	2545584	➤ Sign Up
Spain	2524026	➤ Sign Up
Mexico	2010006025	➤ Sign Up
Russian Federation	2006121341	➤ Sign Up
Country	Document Number	Estimated Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter

Accenture

Covington

Merck

Cantor Fitzgerald

Fuji

Fish and Richardson

AstraZeneca

Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.